Elevated BMI Linked to Postacute Sequelae of SARS-CoV-2 in Children
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 30, 2024 -- For children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, elevated body mass index (BMI) is associated with an increased risk of postacute sequelae of SARS-CoV-2 infection (PASC), according to a study published online Oct. 28 in JAMA Network Open.
Ting Zhou, M.D., Ph.D., from the University of Pennsylvania in Philadelphia, and colleagues conducted a retrospective cohort study in 26 U.S. children's hospitals to quantify the association of BMI status before SARS-CoV-2 infection with pediatric PASC risk. Data were included for 172,136 participants (mean age at cohort entry, 13.1 years).
The researchers found that participants with obesity and severe obesity had a significantly increased risk for PASC compared with those with healthy weight (relative risks, 1.25 and 1.42, respectively) when identified using the diagnostic code. There was an increased risk for any occurrences of PASC symptoms and conditions among those with obesity and severe obesity compared with those with healthy weight (relative risks, 1.11 and 1.17, respectively); when assessing total incident occurrences among those with overweight, obesity, and severe obesity, the association held (relative risks, 1.05, 1.13, and 1.18, respectively).
"Addressing obesity as a modifiable risk factor could alleviate the burden of PASC and improve pediatric health postpandemic," the authors write. "Further research is needed to explore specific PASC symptoms associated with BMI."
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Further Support and Information on COVID-19
Read this next
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.